How Does Inflammation Relate to Cancer?

Name: How Does Inflammation Relate to Cancer?
Start: 2022-03-23T13:00:00-04:00
End: 2022-03-23T14:00:00-04:00

How Does Inflammation Relate to Cancer?

Nutrition and Wellness for Myeloma

Mar 23, 2022 / 01:00PM - 02:00PM EDT

Event Description

This month we are focusing on wellness and what we can do to improve your bodies to fight cancer. What do we know about the relationship between inflammation and cancer? How are the two linked and what suggestions are given to myeloma patients or other cancer patients to reduce or avoid inflammation? Dr. Lee shares with us her insight on this topic. Come with your questions!

Schedule & Agenda

Introduction

01:00PM

Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Sarah Lee, MD.

01:00PM

Audrey Burton-Bethke

Introduction

Audrey introduces the agenda of the event and featured speaker Sarah Lee, MD.

Presentation

01:05PM

Dr. Sarah Lee

Dr. Lee shares her insight on the relationship between inflammation and cancer.

01:05PM

Dr. Sarah Lee

Presentation

Dr. Lee shares her insight on the relationship between inflammation and cancer.

Questions and Answers

01:35PM

Audience

Type your questions in the chat and we will answer them!

01:35PM

Audience

Questions and Answers

Type your questions in the chat and we will answer them!

Speakers & Moderators

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio

Sarah Lee, MD

Dr. Lee is a hematologist-oncologist who specializes in the care of patients with plasma cell disorders. Before joining SCCA, she completed a fellowship in hematology-oncology at the Cleveland Clinic. Her background also includes experience in researching novel therapies for multiple myeloma, amyloidosis, and other plasma cell disorders. What drew her to SCCA was the opportunity to participate in clinical research and to embrace a collaborative approach to medicine.

Read Bio